The UAE AI in healthcare market size reached USD 39.00 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 337.90 Million by 2033, exhibiting a growth rate (CAGR) of 24.10% during 2025-2033. Rapid digital transformation, increasing chronic disease burden, strategic government initiatives, and robust healthcare infrastructure support UAE AI in healthcare market share.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 39.00 Million |
Market Forecast in 2033 | USD 337.90 Million |
Market Growth Rate 2025-2033 | 24.10% |
Diagnostic Innovation
The UAE AI in healthcare market increasingly leverages AI-powered diagnostic tools. Medical centers deploy AI-enhanced imaging systems to automate radiology and pathology analytics, reducing diagnostic errors and clinician workloads. Government partnerships, such as those at the Dubai Health Innovation Centre, pilot AI-assisted disease detection. For instance, in May 2025, Oracle, Cleveland Clinic, and G42 formed a strategic partnership to create a global AI-based healthcare delivery platform. The initiative will use AI, advanced analytics, and real-time data to enhance diagnostics, personalize treatments, improve outcomes, and reduce healthcare costs. The platform positions UAE as a global health innovation leader. This trend demonstrates a shift toward precision diagnostics and reinforces the role of UAE AI in healthcare market growth.
Remote Monitoring Expansion
Another key trend in the UAE AI in healthcare market involves adoption of AI-driven patient monitoring systems. Healthcare providers employ connected sensors and virtual assistants for remote symptom assessment, chronic disease management, and appointment coordination. These technologies alleviate hospital burden, enhance care continuity, and support proactive interventions. The trend signals a transition toward decentralized, AI-enabled care delivery models in the UAE AI in healthcare sector. For instance, the UAE is revolutionizing healthcare regulation with a new AI-powered National Unified Digital Platform set to launch in Q2 2026. It will streamline licensing for over 200,000 healthcare professionals annually, supporting the nation's “Zero Government Bureaucracy” vision and positioning the UAE as a global model for efficient, tech-driven healthcare governance.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the regional and country levels for 2025-2033. Our report has categorized the market based on offering, technology, application, and end user.
Offering Insights:
The report has provided a detailed breakup and analysis of the market based on the offering. This includes hardware, software, and services.
Technology Insights:
A detailed breakup and analysis of the market based on technology have also been provided in the report. This includes machine learning, context-aware computing, natural language processing, and others.
Application Insights:
The report has provided a detailed breakup and analysis of the market based on the application. This includes robot-assisted surgery, virtual nursing assistant, administrative workflow assistance, fraud detection, dosage error reduction, clinical trial participant identifier, preliminary diagnosis, and others.
End User Insights:
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes preliminary diagnosis, pharmaceutical and biotechnology companies, patients, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Dubai, Abu Dhabi, Sharjah, and others.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Offerings Covered | Hardware, Software, Services |
Technologies Covered | Machine Learning, Context-Aware Computing, Natural Language Processing, Others |
Applications Covered | Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, Others |
End Users Covered | Preliminary Diagnosis, Pharmaceutical and Biotechnology Companies, Patients, Others |
Regions Covered | Dubai, Abu Dhabi, Sharjah, Others |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: